Skip to main content

Advertisement

SpringerLink
Log in

Potential Effects of Calcium Binding Protein S100A12 on Severity Evaluation and Curative Effect of Severe Acute Pancreatitis

  • Published:
Inflammation Aims and scope Submit manuscript

An Erratum to this article was published on 09 December 2014

Abstract

Severe acute pancreatitis is a life threatening disease with a high rate of mortality, but its treatments are still controversial. The purpose of this study is to investigate the potential effects of calcium binding protein S100A12 on severity evaluation and curative effect of severe acute pancreatitis induced by caerulein and lipopolysaccharide in mice. Intraperitoneal injection of 50 μg/kg caerulein for seven times (every interval time was an hour) and intraperitoneal injection of 10 mg/kg lipopolysaccharide for once to establish acute pancreatitis mice models. One hundred sixty specific pathogen-free imprinting control region (ICR) female mice were randomly divided into the control group (group A, normal saline), the mild group (group B, caerulein), the severe group (group C, caerulein + lipopolysaccharide), and the intervention group (group D, S100A12 recombinant antibodies + caerulein + lipopolysaccharide); each group had 40 mice. We sampled the blood at 8, 12, and 24 h after the beginning of building animal models. In each period of time, we respectively detected the serum S100A12, amylase (AMY), C-reactive protein (CRP), interleukin (IL-1β, IL-6), and tumor necrosis factor (TNF-α) levels. In addition, we observed and scored the pancreas and lungs histopathology of the mice. In each same period of time compared with group C, serum AMY, CRP, IL-1β, IL-6, TNF-α levels of group D were significantly decreased (p < 0.05). In each same period of time compared with group B and group C, serum S100A12 concentration of group D was significantly decreased (p < 0.05), and the pancreas and lungs histopathology were also much improved. These observations demonstrate that S100A12 recombinant antibodies were able to significantly reduce the severity of acute pancreatitis induced by caerulein and lipopolysaccharide in mice. Serum S100A12 may serve as a useful marker for disease severity and curative effect in mice with severe acute pancreatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sekimoto, M., T. Takada, Y. Kawarada, et al. 2006. JPN guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 13: 10–24.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Granger, J., and D. Remick. 2005. Acute pancreatitis: models, markers, and mediators. Shock 24(Suppl 1): 45–51.

    Article  CAS  PubMed  Google Scholar 

  3. Mayerle, J., V. Hlouschek, and M.M. Lerch. 2005. Current management of acute pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2: 473–483.

    Article  PubMed  Google Scholar 

  4. Scheiber-Camoretti, R., A. Mehrotra, L. Yan, J. Raman, J.F. Beshai, and M.A. Hofmann Bowman. 2013. Elevated S100A12 and sRAGE are associated with increased length of hospitalization after non-urgent coronary artery bypass grafting surgery. Am J Cardiovasc Dis 3(2): 85–90.

    PubMed Central  CAS  PubMed  Google Scholar 

  5. Shiotsu, Y., Y. Mori, M. Nishimura, T. Hatta, N. Imada, N. Maki, K. Iida, N. Iwamoto, E. Matsuoka, K. Tamagaki, and A. Kosaki. 2013. Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan. BMC Nephrol 16: 14–16.

    Google Scholar 

  6. Saito, T., Y. Hojo, Y. Ogoyama, et al. 2012. S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease. Circ J 76(11): 2647–2652.

    Article  CAS  PubMed  Google Scholar 

  7. Shiotsu, Y., Y. Mori, M. Nishimura, et al. 2011. Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. Clin J Am Soc Nephrol 6(4): 718–723.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Mori, Y., A. Kosaki, N. Kishimoto, et al. 2009. Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis. Am J Nephroi 29(1): 18–24.

    Article  CAS  Google Scholar 

  9. Manolakis, A.C., A.N. Kapsoritakis, P. Georgoulias, et al. 2010. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol 10: 118.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Foell, D., T. Kucharzik, M. Kraft, et al. 2003. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52(6): 847–853.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Leach, S.T., Z. Yang, I. Messina, et al. 2007. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol 42(11): 1321–1331.

    Article  CAS  PubMed  Google Scholar 

  12. Kaiser, T., J. Langhorst, H. Wittkowski, et al. 2007. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 56(12): 1706–1713.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Lorenz, E., M.S. Muhlebach, P.A. Tessier, et al. 2008. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respir Med 102(4): 567–573.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Foell, D., S. Seeliger, T. Vogl, H.G. Koch, H. Maschek, E. Harms, C. Sorg, and J. Roth. 2003. Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 58(7): 613–617.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Wittkowski, H., A. Stumock, M.A. van Zoelen, et al. 2007. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 35(5): 1369–1375.

    Article  PubMed  Google Scholar 

  16. Shepherd, C.E., J. Goyette, V. Utter, et al. 2006. Inflammatory S100A9 and S100A12 proteins in Alzheimer’s disease. Neurobiol Aging 27(11): 1554–1563.

    Article  CAS  PubMed  Google Scholar 

  17. Komatsuda, A., H. Ohtani, H. Wakui, et al. 2006. Increased serum levels of S100A12 in patients with MPO-ANCA-associated glomerulonephritis. Clinical Nephrology 66(5): 315–321.

    Article  CAS  PubMed  Google Scholar 

  18. Kosaki, A., T. Hasegawa, T. Kimura, et al. 2004. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. Journal of Clinical Endocrinology Metabolism 89(11): 5423–5428.

    Article  CAS  PubMed  Google Scholar 

  19. Liao, H., J. Wu, E. Kuhn, et al. 2004. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheumatism 50(12): 3792–3803.

    Article  CAS  PubMed  Google Scholar 

  20. Foell, D., D. Kane, B. Bresnihan, et al. 2003. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 42(11): 1383–1389.

    Article  CAS  Google Scholar 

  21. Foell, D., H. Wittkowski, I. Hammerschmidt, et al. 2004. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheumatism 50(4): 1286–1295.

    Article  CAS  PubMed  Google Scholar 

  22. Ye, F., D. Foell, K. Hirono, et al. 2004. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. American Journal of Cardiology 94(6): 840–844.

    Article  CAS  PubMed  Google Scholar 

  23. Foell, D., F. Ichida, T. Vogl, et al. 2003. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 361(9365): 1270–1272.

    Article  CAS  PubMed  Google Scholar 

  24. Guignard, F., J. Mauel, and M. Markert. 1995. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem Journal 309(Pt 2): 395–401.

    CAS  Google Scholar 

  25. Pietzsch, J., and S. Hoppmann. 2009. Human S100A12: a novel key player in inflammation? Amino Acids 36(3): 381–389.

    Article  CAS  PubMed  Google Scholar 

  26. Schmidt, J., D.W. Rattner, K. Lewandrowski, C.C. Compton, U. Mandavilli, W.T. Knoefel, and A.L. Warshaw. 1992. A better model of acute pancreatitis for evaluating therapy. Annalytical Surgery 215(1): 44–56.

    Article  CAS  Google Scholar 

  27. Schmidt, J., K. Lewandrowski, C. Fernandez-del Castillo, U. Mandavilli, C.C. Compton, A.L. Warshaw, and D.W. Rattner. 1992. Histopathologic correlates of serum amylase activity in acute experimental pancreatitis. Dig Dis Sci 37(9): 1426–1433.

    Article  CAS  PubMed  Google Scholar 

  28. Sandler, R.S., J.E. Everhart, M. Donowitz, et al. 2002. The burden of selected digestive diseases in the United States. Gastroenterology 122: 1500–1511.

    Article  PubMed  Google Scholar 

  29. Christophe, R., C. Laurence, K. Scott, et al. 2002. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Research 62: 1868–1875.

    Google Scholar 

  30. Rouleau, P., K. Vandal, C. Rvckman, et al. 2003. The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. Clinical Immunology 107(1): 46–54.

    Article  CAS  PubMed  Google Scholar 

  31. Mikkelsen, S.E., V. Novitskaya, M. Kriajevska, et al. 2001. S100A12 protein is a strong inducer of neurite outgrowth from primary hippocampal neurons. J Neuro 79(4): 767–776.

    CAS  Google Scholar 

  32. Gottsch, J.D., S.W. Eisinger, and S.H. Liu. 1999. Calgranulin C has filariacidal and filariastatic activity. Infect Immun 67(12): 6631–6636.

    PubMed Central  CAS  PubMed  Google Scholar 

  33. Steer, M. 2002. Pancreatitis severity: who calls the shots? Gastroenterology 122: 1168–1172.

    Article  PubMed  Google Scholar 

  34. Sandoval, D., A. Gukovskaya, P. Reavey, et al. 1996. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology 111: 1081–1091.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Quzhou Hospital of Zhejiang University, Quzhou, 324000, Zhejiang, People’s Republic of China

    Zhan Yinchu, Zhang Feng & Shi Yinsheng

  2. The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China

    Zhang Feng, Wu Fengqing, Zhou Xiaoyang, Li Jin & Gao Xiaofei

Authors
  1. Zhan Yinchu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhang Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shi Yinsheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wu Fengqing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhou Xiaoyang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gao Xiaofei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhang Feng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yinchu, Z., Feng, Z., Yinsheng, S. et al. Potential Effects of Calcium Binding Protein S100A12 on Severity Evaluation and Curative Effect of Severe Acute Pancreatitis. Inflammation 38, 290–297 (2015). https://doi.org/10.1007/s10753-014-0032-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-014-0032-x

KEY WORDS

Search

Navigation